Constellation Pharmaceuticals, Inc.
COMBINATIONS OF EZH2 INHIBITORS WITH FURTHER AGENTS FOR USE IN THE TREATMENT OF CANCER
Last updated:
Abstract:
Provided herein are methods of treating cancer using an effective amount of an EZH2 inhibitor and an effective amount of a second agent. Also provided are compositions comprising an EZH2 inhibitor and an effective amount of a second agent.
Status:
Application
Type:
Utility
Filling date:
27 Jul 2016
Issue date:
26 Mar 2020